Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Eisai
Company Monitoring Page for Eisai
job ratings for Eisai
11/18/19
industry:
Big Pharma
company:
Eisai
job rating:
1
bad management
03/19/18
industry:
Big Pharma
company:
Eisai
job rating:
2
Micro managers
04/04/17
industry:
Neurology pharmaceutical Sales
job title:
Neurology salespecially specialist
company:
Eisai
job rating:
1
Poor pay, awful management, no respect for current reps kept through downsizing
latest headlines for company on cafepharma
Lilly Alzheimer's med glides out of Leqembi's slipstream with FDA adcomm request
Fierce Biotech
Wed, 04/17/24 - 09:58 pm
Tags:
Eli Lilly
,
donanemab
,
Alzheimer's disease
,
Leqembi
,
Biogen
,
Eisai
,
FDA
Biogen and Eisai Fall Behind on Leqembi’s Subcutaneous BLA for Alzheimer’s
BioSpace
Mon, 04/1/24 - 12:14 pm
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
Leqembi
Eisai and Biogen facing delay to Leqembi in Europe
Pharmaphorum
Mon, 03/25/24 - 11:22 am
Tags:
Eisai
,
Biogen
,
Leqembi
,
Europe
,
Alzheimer's disease
Eisai backs Leqembi’s Japan rollout with insurance policy
Pharmaphorum
Thu, 03/21/24 - 11:19 am
Tags:
Eisai
,
Lifenet
,
insurance
,
Leqembi
,
dementia
FDA guidelines consider amyloid reduction 'reasonably likely' to predict Alzheimer's benefit
Fierce Biotech
Tue, 03/12/24 - 11:34 am
Tags:
Biogen
,
Eisai
,
Aduhelm
,
FDA
,
Alzheimer's disease
,
amyloid
,
Eli Lilly
,
donanemab
Tau, anti-inflammation and orals form Biogen's future Alzheimer's pipeline
Fierce Biotech
Thu, 03/7/24 - 11:38 am
Tags:
Biogen
,
Alzheimer's disease
,
anti-tau antibodies
,
anti-inflammatory
,
Eisai
,
Leqembi
Japan's Eisai says US introduction of Alzheimer's drug Leqembi slower than expected
Reuters
Thu, 03/7/24 - 11:07 am
Tags:
Eisai
,
Leqembi
,
drug launches
,
Alzheimer's disease
Eisai, Biogen likely to miss early launch goal for Alzheimer's drug Leqembi
Fierce Pharma
Wed, 02/7/24 - 11:33 am
Tags:
Eisai
,
Biogen
,
FDA
,
Medicare
,
Leqembi
,
Alzheimer's disease
EU regulators to consult advisers in review of Eisai Alzheimer’s drug
BioPharma Dive
Thu, 01/11/24 - 08:40 pm
Tags:
Eisai
,
Leqembi
,
Europe
,
Alzheimer's disease
Eisai files biliary tract cancer drug tasurgratinib in Japan
Pharmaphorum
Mon, 12/18/23 - 10:14 am
Tags:
Eisai
,
Japan
,
tasurgratinib
,
biliary tract cancer
Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial
Reuters
Fri, 12/8/23 - 09:59 am
Tags:
Merck
,
Eisai
,
4523.T
,
clinical trials
,
endometrial cancer
,
Keytruda
,
Lenvima
Eisai expects Alzheimer's drug to rake in revenue of $66.5 million by March
Reuters
Tue, 11/7/23 - 09:57 am
Tags:
Eisai
,
Leqembi
,
Alzheimer's disease
Eisai says new data could support more convenient form of Alzheimer’s drug Leqembi
BioPharma Dive
Wed, 10/25/23 - 10:42 pm
Tags:
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
As 'harvest time' arrives for Alzheimer's, neuroscientist reflects on next steps for drug development
Fierce Biotech
Mon, 10/16/23 - 10:12 am
Tags:
Alzheimer's disease
,
Biogen
,
Eisai
,
Eli Lilly
,
Leqembi
,
donanemab
Biogen's Aduhelm headache returns as appeals court revives part of investor lawsuit
Fierce Pharma
Thu, 10/12/23 - 05:18 pm
Tags:
Biogen
,
Aduhelm
,
legal
,
Eisai
,
Alzheimer's disease
6 Drugs Approved Despite Failed Trials or Minimal Data
BioSpace
Mon, 10/9/23 - 11:10 am
Tags:
Ipsen
,
Sohonos
,
Sarepta Therapeutics
,
Elevidys
,
Biogen
,
Qalsody
,
Eisai
,
Aduhelm
,
Jazz Pharma
,
PharmaMar
,
Zepzelca
,
Acadia Pharma
,
Nuplazid
Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen
Reuters
Tue, 09/26/23 - 10:23 am
Tags:
Biogen
,
Eisai
,
Japan
,
Leqembi
,
Alzheimer's disease
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
Fri, 09/22/23 - 11:46 am
Tags:
Merck
,
Eisai
,
Keytruda
,
Lenvima
,
melanoma
,
colorectal cancer
,
non-small cell lung cancer
Eisai launches digital dementia specialist company
Pharmaphorum
Tue, 09/12/23 - 12:06 pm
Tags:
Eisai
,
digital health
,
dementia
,
Theoria Technologies
The Alzheimer’s Treatment Landscape: Leqembi vs. Donanemab
BioSpace
Mon, 09/11/23 - 11:56 am
Tags:
Alzheimer's disease
,
Eli Lilly
,
Biogen
,
Eisai
,
Leqembi
,
donanemab
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.